CI Investments Inc’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-323
Closed -$32K 666
2019
Q3
$32K Buy
+323
New +$30.7K ﹤0.01% 570
2019
Q1
Sell
-2,000
Closed -$128K 384
2018
Q4
$128K Buy
+2,000
New +$148K ﹤0.01% 301
2018
Q1
Sell
-541,450
Closed -$56.5M 234
2017
Q4
$56.5M Sell
541,450
-127,000
-19% -$14.3M 0.58% 58
2017
Q3
$97.5M Buy
668,450
+2,200
+0.3% +$300K 0.95% 36
2017
Q2
$86.5M Buy
666,250
+42,600
+7% +$5.22M 0.94% 34
2017
Q1
$77.6M Sell
623,650
-15,900
-2% -$1.9M 0.88% 37
2016
Q4
$74M Buy
639,550
+322,100
+101% +$35.9M 0.81% 40
2016
Q3
$33.2M Buy
+317,450
New +$34.4M 0.36% 79
2015
Q3
Sell
-5,000
Closed -$579K 209
2015
Q2
$579K Hold
5,000
0.01% 178
2015
Q1
$576K Buy
+5,000
New +$597K 0.01% 172

Other funds holding CELG

CI Investments Inc's CELG Position: Q4 2019 in Review

CI Investments Inc sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 323 shares — an estimated $32K sold.

CI Investments Inc first reported a position in CELG in Q1 2015 and held it in 10 quarters. The position peaked at $97.5M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • CI Investments Inc reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • CI Investments Inc sold 323 Celgene Corp shares in Q4 2019, an estimated $32K.
  • CI Investments Inc first reported a position in Celgene Corp in Q1 2015 and held it in 10 quarters.
  • CI Investments Inc's Celgene Corp position peaked at $97.5M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on CI Investments Inc's 13F filing for Q4 2019, filed 11 Feb 2020.